• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Caladrius Bio (NQ: CLBS )

    N/A UNCHANGED
    Last Price Updated: 4:00 PM EDT, Sep 14, 2022 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Headline News about Caladrius Bio

    < Previous 1 2 Next >
    Why Vintage Wine Estates Shares Tumbled 40%; Here Are 70 Biggest Movers From Yesterday
    Gainers AMTD Digital Inc. (NYSE: HKD) shares jumped 311.8% to settle at $189.42 on Wednesday as the stock experienced a resurgence in momentum despite a lack of fundamental news. 
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Intraday Session
      
    Via Benzinga
    Caladrius Biosciences Stops Enrollment In Mid-Stage Heart Disease Study
    Via Benzinga
    Caladrius Biosciences To Merge With Privately-Held Cend Therapeutics
    Via Benzinga
    Why SciSparc Is Trading Higher By 68%, Here Are 48 Stocks Moving In Wednesday's Mid-Day Session
    Gainers Akerna Corp. (NASDAQ: KERN) shares rose 81.2% to $0.2355 after gaining 8% on Tuesday. 
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Pre-Market Session
      
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
    We're starting off the final trading day of the week with an overview of the biggest pre-market stock movers for Friday! 
    Via InvestorPlace
    Why Pagerduty Is Trading Higher By 9%; Here Are 28 Stocks Moving Premarket
    Gainers 
    Via Benzinga
    Biotech Daily: Cancer Causing Impurities In Merck's Diabetic Drug, Vir Bio-GSK Shun FDA Submission Plans For COVID-19 Treatment, Aethlon's Monkeypox Trial
    Here's a roundup of top developments in the biotech space over the last 24 hours: 
    Via Benzinga
    Earnings Outlook For Caladrius Biosciences
    Caladrius Biosciences (NASDAQ:CLBS) is set to give its latest quarterly earnings report on Thursday, 2022-08-04. Here's what investors need to know before the announcement. Analysts estimate that... 
    Via Benzinga
    Caladrius Biosciences's Earnings Outlook
    Caladrius Biosciences (NASDAQ:CLBS) is set to give its latest quarterly earnings report on Thursday, 2022-08-04. Here's what investors need to know before the announcement. Analysts estimate that... 
    Via Benzinga
    Recap Of Tuesday's Biotech Catalysts - End Of the Day Summary
    Via Benzinga
    The Daily Biotech Pulse: INmune Bio's Planned Alzheimer's Trial On FDA Hold, Caladrius Stops Enrollment In Heart Disease Study, BiomX Restructures
    Here's a roundup of top developments in the biotech space over the last 24 hours: 
    Via Benzinga
    28 Stocks Moving in Thursday's Pre-Market Session
    Gainers T Stamp Inc. (NASDAQ: IDAI) shares rose 103.3% to $4.27 in pre-market trading after gaining over 8% on Wednesday. Trust Stamp recently posted Q4 net sales of $2.1... 
    Via Benzinga
    74 Biggest Movers From Yesterday
    Gainers T Stamp Inc. (NASDAQ: IDAI) shares surged 123.8% to close at $4.70 on Thursday. Trust Stamp reported the launch of its Biometric Multi-Factor Authentication (Biometric... 
    Via Benzinga
    The Daily Biotech Pulse: Molecular Partners Plunges On Double Bad News, Pfizer/BioNTech Seek Nod For COVID-19 Shot In Kids, Pfizer Invests In Zentalis
    Here's a roundup of top developments in the biotech space over the last 24 hours. 
    Via Benzinga
    48 Stocks Moving In Thursday's Mid-Day Session
    Gainers T Stamp Inc. (NASDAQ: IDAI) shares jumped 201% to $6.33. Trust Stamp reported the launch of its Biometric Multi-Factor Authentication (Biometric MFATM) solution. Statera... 
    Via Benzinga
    The Daily Biotech Pulse: Pfizer Reports Positive Ulcerative Colitis Study Data, Novavax COVID Shot Authorized For Adolescents In India, Argenx Stock Sale
    Here's a roundup of top developments in the biotech space over the last 24 hours. 
    Via Benzinga
    Recap: Caladrius Biosciences Q4 Earnings
    Caladrius Biosciences (NASDAQ:CLBS) reported its Q4 earnings results on Tuesday, March 22, 2022 at 04:30 PM. Here's what investors need to know about the announcement.... 
    Via Benzinga
    The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Pfizer Strikes COVID-19 Pill Supply Deal, Argenx Reports Positive Late-Stage Readout
    Here's a roundup of top developments in the biotech space over the last 24 hours: 
    Via Benzinga
    Earnings Scheduled For March 22, 2022
    Companies Reporting Before The Bell • GDS Holdings (NASDAQ:GDS) is projected to report quarterly loss at $0.18 per share on revenue of $338.69 million. • HUYA (... 
    Via Benzinga
    Caladrius Biosciences Earnings Preview
    Caladrius Biosciences (NASDAQ:CLBS) is set to give its latest quarterly earnings report on Tuesday, 2022-03-22. Here's what investors need to know before the announcement.... 
    Via Benzinga
    The Week Ahead In Biotech (March 20-26): Focus On Zogenix FDA Decision, Dermatology Conference Presentations & Earnings
    Biotech stocks rebounded along with the broader market in the week ending March 18, as risk appetite returned. Multiple conference presentations, clinical readouts and earnings news dictated sentiment... 
    Via Benzinga
    12 Health Care Stocks Moving In Friday's After-Market Session
    Gainers HOOKIPA Pharma (NASDAQ:HOOK) stoc... 
    Via Benzinga
    21 Stocks Moving in Wednesday's Pre-Market Session
    Gainers Wejo Group Ltd (NASDAQ: WEJO) rose 37% to $8.63 in pre-market trading after the company announced a new connected vehicle platform with Microsoft, called Wejo Neural Edge... 
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Gainers Hoth Therapeutics (NASDAQ: 
    Via Benzinga
    5 Penny Stocks Insiders Are Buying
    When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders intereste... 
    Via Benzinga
    The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO
    Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck's Oral Antiviral COVID-19 Pill Authorized In UK Merck &... 
    Via Benzinga
    Exposures COVID-19
    The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
    Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc... 
    Via Benzinga
    The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results
    Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 6) Enanta Pharmaceuticals, Inc... 
    Via Benzinga
    < Previous 1 2 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.